Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

NCT00779922 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT00779922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00779922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
Lead sponsor
Poitiers University Hospital
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
Not reported
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

impaired renal function, multiple myeloma